Latest Long-term potentiation Stories
WASHINGTON, Nov. 17, 2014 /PRNewswire/ -- Naurex Inc.
There are new clues about malfunctions in brain cells that contribute to intellectual disability and possibly other developmental brain disorders.
A new study is focusing on the manipulation of memory in the hopes that cognitive diseases can be identified and treated. As is the case with many brain studies, the subjects the researchers are focusing on are genetically engineered rats.
Two new publications by a team from Western University of Health Sciences shed further light on the mechanisms of learning and memory, and neuronal degeneration. Pomona,
A team of neuroscientists has identified a modification to a protein in laboratory mice linked to conditions associated with Alzheimer's Disease.
In a new study in Neuron, scientists identified specific key steps in the chain of events that causes stress-related drug relapse.
In the journal PLoS Biology, a team of scientists reports experiments showing how the gene defect of Angelman syndrome disrupts neurological processes that may be needed for memory and learning.
A team of scientists has found a novel road-block in the pain pathway, which could be used to treat chronic pain.
Biomedical scientists at the University of California, Riverside have identified a new link between a protein called beta-arrestin and short-term memory that could open new doors for the therapeutic treatment of neurological disorders, particularly Alzheimer's disease.
About half of newborns who have seizures go on to have long-term intellectual and memory deficits and cognitive disorders such as autism, but why this occurs has been unknown.
- Inward knowledge; understanding; conscience.